Mecaro Co Ltd

Mecaro Co Ltd maintains a strong liquidity position, with a current ratio of 10.16, indicating that the company has significantly more current assets than current liabilities. The company also holds a substantial amount of cash and equivalents, totaling 23,481,296,110 KRW, which supports its short-term obligations and operational flexibility. However, the company reported negative free cash flow of -5,663,334,140 KRW, primarily due to a large capital expenditure of -11,502,574,870 KRW, which suggests significant investment in long-term assets.

In terms of profitability, Mecaro's return on equity (ROE) is 0.0019 and return on assets (ROA) is 0.0018, both of which are relatively low compared to industry benchmarks for specialty chemicals. This indicates that the company is not generating strong returns relative to its equity and asset base. The company's operating income of 464,953,510 KRW and net income of 358,458,720 KRW reflect modest profitability, with a gross profit of 6,122,041,520 KRW.

Mecaro's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. The company's primary operations are based in South Korea, and there is no indication of significant international revenue streams. This concentration may expose the company to regional economic and regulatory risks.

The company's growth trajectory appears to be modest, with no significant revenue growth reported in the latest financial period. Mecaro's revenue for the period was 13,690,359,420 KRW, and there is no indication of a substantial increase in the near term. The company's capital expenditures suggest a focus on maintaining or expanding its production capabilities, but the negative free cash flow indicates that these investments are not yet generating positive cash returns.

Mecaro's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal reliance on debt financing. However, the negative free cash flow and high capital expenditures may signal potential future liquidity constraints if the company's cash generation does not improve.

Recent financial filings and transcripts do not indicate any material events or changes in the company's operations or strategy. The company's latest actual EPS was reported as -168.00 KRW, which is below the analyst estimates, suggesting underperformance relative to expectations.

Revenue surged 50.5% year-over-year to 94.6 billion KRW, demonstrating strong top-line growth momentum for the company.

Operating income jumped 257.8% to 14.7 billion KRW, indicating significant improvement in core operational profitability.

Free cash flow turned positive at 8.9 billion KRW, reversing previous deficits and enhancing financial flexibility.

Cash conversion of 12.78 ranks as best-in-class within the Specialty Chemicals cohort, highlighting superior efficiency.

Debt-to-equity ratio of 0.01 is above the 75th percentile, reflecting a conservative capital structure with minimal leverage.

Return on equity of 0.19% sits in the bottom quartile of the Specialty Chemicals cohort, signaling poor capital efficiency.

Return on assets of 0.18% is extremely low, reflecting minimal profit generation from the company's asset base.

Revenue KRW 38.59B, −28,5% YoY; Operating income −449,4% YoY.

• ▍Revenue KRW 38.59B, −28,5% YoY
• ▍Operating income −449,4% YoY
• ▍Net income −105,4% YoY
• ▍Free cash flow −193,4% YoY
• ▍Net margin -6.1%